Oncternal Therapeutics, Inc.
(NASDAQ : ONCT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.74%33.500.9%$1136.55m
JNJJohnson & Johnson -0.37%142.740.7%$1075.07m
BMYBristol-Myers Squibb Co. -2.36%58.161.0%$944.64m
MRKMerck & Co., Inc. -1.45%76.790.7%$804.84m
ABBVAbbVie, Inc. -1.53%97.762.3%$772.99m
LLYEli Lilly & Co. -1.57%166.481.1%$685.12m
VXRTVaxart, Inc. 1.35%8.260.0%$290.34m
AZNAstraZeneca Plc -0.33%54.011.2%$289.11m
RPRXRoyalty Pharma Plc 0.02%48.030.1%$226.55m
NVSNovartis AG -0.76%87.450.2%$150.36m
RGENRepligen Corp. 2.82%128.827.2%$120.54m
GSKGlaxoSmithKline Plc -0.91%40.360.2%$111.43m
NVONovo Nordisk A/S -0.56%65.510.1%$93.67m
RETAReata Pharmaceuticals, Inc. -0.73%156.853.4%$81.53m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -2.05%76.350.0%$71.79m

Company Profile

Oncternal Therapeutics, Inc. is a clinical-stage oncology company, which develops a diverse pipeline of treatments for cancers with critically unmet medical need. It focuses on drug development of untapped biological pathways implicated in cancer progression. The company was founded by David F. Hale and James B. Breitmeyer in 1997 and is headquartered in San Diego, CA.